Physician
Infectious Disease
Dr. Lee R. Brettman, MD
|
|
Give Review
Brettman works in the field of Infectious Disease. He went to medical school at NYU School of Medicine. Lee R. Brettman, MD is also published. He has 25 publications published. The lastest publication: "Pharmacokinetics and safety of single oral doses of VX-366 (isobutyramide) in healthy volunteers.'
Publications
- Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administra...
- Anti-adhesion molecule therapy as an interventional strategy for autoimmune inflammation.
- Pharmacokinetics and safety of single oral doses of VX-366 (isobutyramide) in healthy volunteers.
- Severe necrotizing soft-tissue infections: report of 22 cases.
- Rickettsialpox: report of an outbreak and a contemporary review.
- Infections in hypothermic patients.
- An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction.
- Crystallocryoglobulinemia resulting from human monoclonal antibodies to albumin.
- A multi-hospital hepatitis B vaccine program: prevalence of antibody and acceptance of vaccination among high-risk hospital employees.
- Legionella bozemanii and empyema.
- Hemorrhagic cystitis due to herpes simplex virus as a marker of disseminated herpes infection.
- Infection with the human immunodeficiency virus (HIV) as a risk factor for bacteremic illness due to Streptococcus pneumoniae.
- Recent advances in antimicrobial therapy.
- Actinobacillus actinomycetemcomitans prosthetic valve endocarditis.
- Nosocomial infection: risks associated with short-term and long-term inpatient care.
- Pathogenesis of urinary tract infections: host susceptibility and bacterial virulence factors.
- Chronology of a hospital-wide measles outbreak: lessons learned and shared from an extraordinary week in late March 1989.
- Legionnaires'' disease. A cause of severe abscess-forming pneumonia.
- Population pharmacokinetics-pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic leukaemia and its link to treatment response.
- Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine.
- Phenotypic transformation of CD52(pos) to CD52(neg) leukemic T cells as a mechanism for resistance to CAMPATH-1H.
- Liprotamase long-term safety and support of nutritional status in pancreatic-insufficient cystic fibrosis.
- International phase III trial of liprotamase efficacy and safety in pancreatic-insufficient cystic fibrosis patients.
- Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.
Schools
Baylor University
University Hosps Case West Res
Bellevue Hospital Nyu Med Center
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
NYU School of Medicine -
Baylor College of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Anthony P. Lopez, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vibha Sharma, MD
This Doctor is OpenDoctor Recommended.
|